Millennium Pharmaceuticals, Inc. (MLNM)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
3044	135	0	MLNM

Emcee: icanpickem	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1944	Celgene helpfully list their abstracts in full, together with the numbers - Mess	nigel bates	-	12/3/2003
1943	New Data on VELCADE(TM) (bortezomib) for Injection to be Presented at Upcoming A	IRWIN JAMES FRANKEL	-	12/3/2003
1942	Now PFE (was Pharm.) FLT3 inhibitor. Significant toxicity at higher doses (100 m	Miljenko Zuanic	-	11/20/2003
1941	[5286] The Effect of Bortezomib (Velcade) on Bone Disease in Multiple Myeloma. S	Icebrg	-	11/17/2003
1940	[353] A phase I trial of the proteasome inhibitor bortezomib and pegylated lipos	Icebrg	-	11/16/2003
1939	[369] Proteasome inhibitor bortezomib (Velcade) and trastuzumab in HER-2 overexp	Icebrg	-	11/16/2003
1938	Cancer Res. 2003 Nov 1;63(21):7338-44. The Proteasome Inhibitor Bortezomib St	scaram(o)uche	-	11/14/2003
1937	...cont In their analysis of the medical data of 56,264 patients in the CRUSADE	Icebrg	-	11/11/2003
1936	Drug Proven to Benefit Heart Attack Victims Vastly Underused Tuesday November 11	Icebrg	-	11/11/2003
1935	The drug appears to be Integrilin?! Cheers, Tuck	tuck	-	11/11/2003
1934	[MLN-464(?) for cancer] This first showed up in PNAS today despite the Washingt	tuck	-	11/11/2003
1933	From Briefing.com: >>10:59AM Millennium Pharma: Near-term news flow shoul	tuck	-	11/7/2003
1932	Circulation. 2003 Nov 3 [Epub ahead of print]. Anticoagulants (Thrombin Inhib	scaram(o)uche	-	11/5/2003
1931	ASH abstracts The abstracts are now available on-line (after a simple registrat	Icebrg	-	11/5/2003
1930	Silencing A Parkinson's Gene Matthew Herper, 10.30.03, 2:30 PM ET NEW YOR	bob zagorin	-	10/30/2003
1929	Studies show Tim-3 proteins key to immune responses BOSTON -- The discovery that	Icebrg	-	10/30/2003
1928	On the third hand, if the program was so successful why abandon it? Even if you	A.J. Mullen	-	10/29/2003
1927	>> OTOH...... << Guffaw! Well, there's the wrench. The statin	scaram(o)uche	-	10/29/2003
1926	One other point (and I could be way off on this, but I think I might be on to so	nigel bates	-	10/29/2003
1925	Yeah, exactly. Drug development is a long, expensive proposition involving both	scaram(o)uche	-	10/29/2003
1924	Patience. :-) :-(	nigel bates	-	10/29/2003
1923	It does seem reminiscent of INCY who trumpeted many selling their services to Bi	A.J. Mullen	-	10/29/2003
1922	Guilford buys rights to drug for $84 mln Wednesday October 29, 8:52 am ET NEW Y	Icebrg	-	10/29/2003
1921	<i>why would Bayer not be required to make both statements in the same pre	nigel bates	-	10/29/2003
1920	>>This just does not smell right.>> It does as a matter of fact sme	Icebrg	-	10/29/2003

Go to reply# or date (mm/dd/yy):